Bladder Cancer Breakthroughs
A Global Perspective on Diagnosis, Treatment, and Patient Care
- 1st Edition - October 16, 2025
- Latest edition
- Editors: Bhupendra G. Prajapati, Devesh U. Kapoor, Abdullah F. AlAsmari
- Language: English
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is a groundbreaking scientific resource that delves into the latest advancements in the… Read more
Data Mining & ML
Unlock the cutting edge
Up to 20% on trusted resources. Build expertise with data mining, ML methods.
Description
Description
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is a groundbreaking scientific resource that delves into the latest advancements in the diagnosis and treatment of bladder cancer, a prevalent malignancy affecting hundreds of thousands worldwide. This meticulously curated volume brings together contributions from leading scientists and healthcare professionals from around the globe, providing a comprehensive overview of contemporary understanding and innovative strategies in managing this complex disease. Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care is not merely a collection of research findings; it is a vital resource that fosters a holistic perspective on patient-centered care. By synthesizing clinical expertise and evidence-based practices, this book aims to empower healthcare providers with the knowledge and tools needed to improve outcomes for individuals living with bladder cancer, ultimately contributing to the global fight against this challenging disease. This book serves as an essential guide for healthcare providers, including physicians, oncologists, immunologists, pharmacists, and physical therapists, striving to enhance patient care and treatment outcomes
Key features
Key features
- Provides an in-depth exploration of bladder cancer, including its epidemiology, risk factors, and cutting-edge diagnostic techniques
- Addresses the latest therapeutic interventions, from traditional surgical methods to innovative approaches using nanotechnology and artificial intelligence, ensuring a holistic understanding of the disease
- Features contributions from leading scientists and healthcare professionals from around the world, emphasizing a global perspective on bladder cancer management
- Designed to educate healthcare providers through clear, evidence-based insights supported by extensive tables, figures, and illustrations. These visual aids enhance comprehension and retention, making complex concepts more accessible and applicable in clinical settings.
Readership
Readership
Researchers working across the biosciences in fields of oncology
Table of contents
Table of contents
1. Epidemiology and risk factors of bladder cancer
2. Diagnosis approaches for bladder cancer
3. Role of hydrogel in bladder cancer treatment
4. Role of Nanoparticles in bladder cancer management
5. Role of Quantum dots in bladder cancer management
6. Nanomaterial based biomarkers in bladder cancer management
7. Role of nanorods in bladder cancer management
8. Role of liposomes in bladder cancer management
9. Role of artificial intelligence in bladder cancer management
10. Role of nanocomposite for bladder cancer management
11. Targeting treatment of bladder cancer employing aptamer conjugates
12. Surgical interventions for bladder cancer management
13. Image guided radiotherapy for bladder cancer management
14. Role of gene sequencing in bladder cancer
15. Addressing and overcoming resistance in bladder cancer treatment
2. Diagnosis approaches for bladder cancer
3. Role of hydrogel in bladder cancer treatment
4. Role of Nanoparticles in bladder cancer management
5. Role of Quantum dots in bladder cancer management
6. Nanomaterial based biomarkers in bladder cancer management
7. Role of nanorods in bladder cancer management
8. Role of liposomes in bladder cancer management
9. Role of artificial intelligence in bladder cancer management
10. Role of nanocomposite for bladder cancer management
11. Targeting treatment of bladder cancer employing aptamer conjugates
12. Surgical interventions for bladder cancer management
13. Image guided radiotherapy for bladder cancer management
14. Role of gene sequencing in bladder cancer
15. Addressing and overcoming resistance in bladder cancer treatment
Product details
Product details
- Edition: 1
- Latest edition
- Published: January 29, 2026
- Language: English
About the editors
About the editors
BP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaDK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs.
Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, IndiaAA
Abdullah F. AlAsmari
Dr. Abdullah AlAsmari was graduated from King Saud University (KSU) with a B.S. in Pharmaceutical Sciences in 2011. In 2013, Dr. AlAsmari joined Auburn University (AU), Harrison School of Pharmacy department of Drug Discovery and Development (DDD) to pursue his PhD under supervision of Dr. Jianzhong Shen and Dr. Amin. In 2017, Dr. AlAsmari returned to KSU with PhD degree and became an assistant professor in the department of Pharmacology & Toxicology. Now he has been promoted as Associate Professor and serving as Vice Dean for Programs and Initiatives at Graduate School at KSU. He is currently working on different funded projects, which aim to induce cardioprotection against different mechanisms that can induce cardiac damage. His research area includes: Cardiovascular Diseases, Mechanisms of cardiotoxicity induced by different anti-cancer drugs. Dr Abdullah has published more than 150 articles in different reputed and peer reviewed journals and several book chapters.
Affiliations and expertise
KIng Saud University, Saudi ArabiaView book on ScienceDirect
View book on ScienceDirect
Read Bladder Cancer Breakthroughs on ScienceDirect